- •Surgical menopause is sudden, so symptoms like hot flashes, poor sleep and low mood are often stronger than in natural menopause.
- •Removing both ovaries before the natural age of menopause has been linked to higher risks of bone loss, heart disease and dementia, especially without estrogen.
- •The Menopause Society advises hormone therapy until about age 51 for most women who lose ovarian function early, unless a medical reason prevents it.
- •If you have had a hysterectomy, you usually need estrogen alone, with no progestogen, and in the WHI estrogen-alone trial breast cancer rates were lower.
- •Some people, including those with certain cancers, need an individual plan, so decide together with a specialist.
What is surgical menopause and how is it different?
Surgical menopause is menopause that begins right after both ovaries are removed, a procedure called a bilateral oophorectomy. It is different from natural menopause because hormone levels fall within hours or days, instead of drifting down over several years.
In natural menopause, the ovaries slow down gradually. Perimenopause can last four to eight years, which gives your body time to adjust. After surgery, estrogen, progesterone and a good share of testosterone drop all at once. That sudden drop is why many women feel symptoms more intensely, including hot flashes, night sweats, poor sleep, mood changes and vaginal dryness.
Not every surgery causes this. A hysterectomy removes the uterus only. You stop having periods, but if your ovaries stay, they usually keep making hormones. Some women still reach menopause a bit earlier after a hysterectomy, but not suddenly. The ovaries are removed in cases like ovarian cancer, severe endometriosis, or risk-reducing surgery for people with BRCA gene changes.
Surgical menopause can also happen after chemotherapy or pelvic radiation, which can stop the ovaries from working. If this happened before age 40, our guide on [premature ovarian insufficiency](/blog/premature-ovarian-insufficiency-early-menopause-before-40) covers the related condition.
The key point is that it is not just "menopause, but earlier." It is a faster, steeper change, and it deserves its own plan.
What symptoms can surgical menopause cause?
Surgical menopause can cause the same symptoms as natural menopause, but they often arrive faster and feel stronger. The most common are hot flashes and night sweats, trouble sleeping, vaginal dryness and discomfort during sex, mood swings or low mood, anxiety, brain fog, joint aches and lower sex drive.
The sudden loss of testosterone matters too. The ovaries make a meaningful share of a woman's testosterone, so energy, mood and desire can dip after surgery. Our guide on [testosterone for women in menopause](/blog/testosterone-for-women-menopause-libido-evidence-guide) explains what the research supports and what it does not.
Some symptoms are quiet. Bone loss starts without any feeling, and cholesterol and blood vessel changes happen unseen. That is one reason doctors pay attention to timing, since the long-term effects matter even when the short-term symptoms seem manageable.
You may also be recovering from the reason for surgery, whether that was cancer, pain or heavy bleeding. That can make it hard to tell which symptoms come from the illness, the operation or the hormone drop. Be patient with yourself, and keep a simple symptom log so your care team can see patterns.
It is also worth saying that many women feel real grief or a sense of loss, especially when surgery ends fertility earlier than planned. That is normal, and support from a counselor or a menopause-informed clinician can help.
Why does removing the ovaries early raise long-term health risks?
Estrogen helps protect bones, blood vessels and the brain, so losing it years before the natural age of menopause means more years without that protection. The research reflects this.
The Mayo Clinic Study of Oophorectomy and Aging, led by Rocca and colleagues, found that women who had their ovaries removed before menopause had a higher risk of cognitive decline and dementia, and that this risk was mostly seen in women who did not take estrogen afterward (Rocca et al., Neurology 2007). In the Nurses' Health Study, women who had both ovaries removed before age 50 and never used estrogen had nearly double the risk of coronary heart disease compared with women who kept their ovaries (Parker et al., Obstetrics and Gynecology 2009). The risk was not seen in women who took estrogen.
Bone health is affected too. Early estrogen loss speeds up bone loss and raises the risk of osteoporosis and fractures. Our [DEXA scan action plan](/blog/osteoporosis-prevention-menopause-dexa-scan-action-plan) shows how to check your bones and protect them.
These are observational studies, which means they show links and not proof. Still, the pattern is consistent across studies, and it is the reason major medical groups treat early menopause as a time when hormone therapy is not only for symptoms but also for long-term health. For a wider look at how the brain fits in, see our article on [menopause and dementia risk](/blog/menopause-and-dementia-risk-does-estrogen-protect-your-brain).
Should you take hormone therapy after surgical menopause?
For most women who have their ovaries removed before 45, yes, hormone therapy is usually recommended until about age 51, unless there is a medical reason to avoid it. That guidance comes from The Menopause Society's 2022 position statement, which says the benefits of hormone therapy generally outweigh the risks for women with early menopause and no contraindications.
The idea is simple. Hormone therapy in this case is more like replacing what your body would have made anyway than adding something extra. The risks seen in studies of older women who start hormones many years after menopause do not apply the same way to younger women replacing missing hormones. Our article on [the HRT window of opportunity](/blog/the-hrt-window-of-opportunity-why-timing-matters) explains why starting age matters.
After about age 51, the decision becomes like any other woman's choice. You and your clinician weigh your symptoms, your bone and heart risk, and your personal and family history. Some women stop, and some continue for symptoms.
There are people for whom hormone therapy is not advised or needs special care. These include some women with a past hormone-sensitive breast cancer, certain clot disorders, or unexplained vaginal bleeding. If that is you, nonhormonal options and local vaginal estrogen may still help, and a specialist can guide you.
This is educational information and not medical advice. The right choice is personal and depends on your health history.
What if you have had a hysterectomy or have a BRCA gene change?
If you have had your uterus removed, you usually take estrogen alone, without a progestogen. Progestogen is added in women who still have a uterus to protect the womb lining from overgrowth. Without a uterus, that protection is not needed, which simplifies treatment.
This matters because the Women's Health Initiative (WHI) estrogen-alone trial, which enrolled women who had had a hysterectomy, did not show higher breast cancer rates. In long-term follow-up, women on estrogen alone had a lower rate of breast cancer, with a hazard ratio of about 0.78 (Chlebowski et al., JAMA 2020). That is different from the combined estrogen and progestin findings, which we discuss in our overview of [HRT and breast cancer risk](/blog/hrt-and-breast-cancer-risk-what-the-whi-data-actually-shows). Women in that trial were mostly older than 50 when they started, so the results do not map perfectly onto younger women.
If you carry a BRCA1 or BRCA2 gene change and had your ovaries removed to reduce cancer risk, hormone therapy is a more individual decision. Studies of BRCA carriers without a breast cancer history have not shown that short-term hormone therapy after surgery raises breast cancer risk, but the evidence is not perfect, and the decision should be made with a genetics-informed specialist.
Progesterone and progestogens may still be used in some cases, for example in women with endometriosis history after surgery. Our guide on [progesterone in menopause](/blog/progesterone-in-menopause-what-it-does-and-why-it-matters) covers when it is needed.
The main message: your surgery type, cancer history and genes all shape the plan.
What forms of hormone therapy are used, and what else can help?
Estrogen comes as patches, gels, sprays, pills and vaginal products. Many clinicians prefer transdermal forms, which are absorbed through the skin, for younger women, because they avoid the first pass through the liver and carry a lower clot risk than oral estrogen in observational studies. Our guide on [patch, pill and gel options](/blog/hrt-patch-vs-pill-vs-gel-which-is-right-for-you) compares them.
Because surgery removes a source of testosterone as well, some women with low desire that persists on estrogen are offered a trial of testosterone. This is an individual decision and not routine for everyone.
Non-medicine steps matter too. Weight-bearing exercise and strength training protect bone. Enough calcium, vitamin D and protein help. Not smoking and limiting alcohol reduce fracture and heart risk. Sleep care, including cognitive behavioral therapy for insomnia, helps with the wake-ups that follow a hormone drop.
If you cannot take hormones, nonhormonal prescription options exist for hot flashes, including newer drugs and certain antidepressants. Vaginal moisturizers and low-dose vaginal estrogen can treat dryness with very little absorption in most women.
Ask your doctor about a baseline bone density scan and a heart risk check. After early surgical menopause, those checks are even more worthwhile. And if you can, bring someone to appointments. There is a lot to take in, and a second set of ears helps.
Can you keep your ovaries when you have a hysterectomy?
Often, yes, and it is worth asking about before surgery. For women having a hysterectomy for a benign (non-cancer) condition, doctors can often leave healthy ovaries in place. The ovaries keep making hormones, which spares you an abrupt menopause.
The tradeoff is that a small number of women develop ovarian cancer later, and ovarian conditions can need more surgery. Doctors weigh that against the long-term risks of losing hormones early. For many younger women at average risk, keeping the ovaries is favored, though practice varies and your own risk factors count.
If you are at high risk of ovarian cancer, for example because of a BRCA gene change, or if you have cancer, removal is often the right choice, and the plan afterward should include a thought-out hormone strategy. Fallopian tubes can be handled separately in some cases, and that is a conversation to have with your surgeon.
Keep in mind that even when ovaries stay, some women reach menopause a few years earlier than expected after a hysterectomy. Watch for hot flashes, sleep problems or mood changes, and mention them to your clinician. Our guide on [premature ovarian insufficiency](/blog/premature-ovarian-insufficiency-early-menopause-before-40) lists early warning signs.
If surgery is already behind you, you are not out of options. Starting a plan today, even later than ideal, is still worthwhile.
Frequently asked questions
- The 2022 hormone therapy position statement of The North American Menopause Society (2022)
- Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause (2007)
- Ovarian conservation at the time of hysterectomy and long-term health outcomes in the Nurses' Health Study (2009)
- Estrogen Alone in Women With Hysterectomy and Long-term Outcomes of the Women's Health Initiative Randomized Trials (2020)
Lea is an AI health companion trained on landmark clinical studies covering GLP-1 medications and menopause. Our content is evidence-based and regularly updated to reflect the latest research.
This article is for informational purposes only and is not medical advice. Always consult your healthcare provider.
Learn more about LeaHave questions about this?
Ask Lea — she'll apply this directly to your medication, your symptoms, your week.
Talk to Lea